News EPFL

Bridging light and electrons

Published:15.01.24 — Researchers at EPFL and Max Planck have merged nonlinear optics with electron microscopy, unlocking new capabilities in material studies and the control of electron beams.

Oral peptides: A new era in drug development

Published:09.01.24 — Scientists at EPFL have developed stable orally available cyclic peptides with a much higher bioavailability than current ones, virtually creating a generation of drugs that can target previously untreatable diseases like certain types of cancer.

Laser additive manufacturing: listening for defects as they happen

Published:11.01.24 — Researchers from EPFL have resolved a long-standing debate surrounding laser additive manufacturing processes with a pioneering approach to defect detection.

Testing automated crack-detection methods for concrete

Published:10.01.24 — An EPFL Master’s student in civil engineering has evaluated the effectiveness of new computer-based methods for inspecting potentially dangerous cracks in concrete. 

Methods for bypassing and treating spinal cord injury

Published:08.01.24 — Grégoire Courtine, Jocelyne Bloch and their research team have been breaking new ground in the treatment of neurological disorders for over a decade. Here’s a look at some of the promising new therapies they’ve developed.

Supercharging CAR-T Cells for Cancer Treatment

Published:04.01.24 — Transformative research at EPFL introduces CAR-T cells that flourish in tumor environments, paving the way for unparalleled advancements in cancer immunotherapy.

Our top 10 news articles from 2023

Published:23.12.23 — We published nearly 300 news articles on EPFL’s homepage in 2023, detailing the latest developments in science, academics, student life, startups and EPFL in general.